Back to index
Back to touts list
View tout dates graph
- Subject: HOT STOCK-Report For July, Last Tracked EMRH, 1Rp | 6 occurrences - low | STT occurs 7 times | View message
- ...Content-Transfer-Encoding: 7Bit Stock Tech-Tracker - HOT NEW Bio-Tech STOCK - KWBTPast Successes - Stocks We Have Recently TrackedCWTD in February - .90 to 8.50 - UP 800 PERCENTMAMA in March - 3.95 to 13.30 - UP over 400 PERCENTAnd we just finished tracking EMRH - UP from 1.00 to 2.08 in just one day. EMRH is a great new company doing business in the fastest growing market in the world - CHINA.Now we are tracking another great company focusing on the Chinese market - KWBT - A HOT NEW BIO-TECH5-Day Target: .8510-Day Target: 1.353-Month Target: 2.50KWBT is a HOT NEW BIO-TECH with manufacturing centers in mainland CHINA.HighLights:*The Chinese agricultural marketplace has a GDP of $180 billion and is 14.5% of the National GDP.*KWBT's main product is a Photosynthesis Biological Catalyst ("Ph-BC"). The first commercialization products in China developed over the last 20 years.*Phase 1 production capacity of 150 tons annually is completed. A 3-year production plan would apply to 12,355,000 acres.*Stimulates plant growth and increases crop yield by as much as 25% based on 3 year field tests.*Sales distribution to over 300 locations throughout China.*Strong Government support with $1.8 million subsidized loan from Chinese government, a $1.2 million loan from the Shandong Province.And with such recent Press Releases as:* June 29 - KWBT Bio-Tech Expands Sales and Marketing Efforts Adding 17 New Customers. Read the whole story HERE.* July 9 - KWBT Bio-Tech Signs Cooperative Letter of Intent. Read the whole story HERE. Stock Tech-Tracker (STT) is not a registered financial advisory. The information presented by STT is not for purchasing or selling securities. STT compiles then distributes opinions, comments and information based on other public sources. Penny stocks are considered to be high...
- ...Content-Transfer-Encoding: 7Bit Stock Tech-Tracker - HOT NEW Bio-Tech STOCK - KWBTPast Successes - Stocks We Have Recently TrackedCWTD in February - .90 to 8.50 - UP 800 PERCENTMAMA in March - 3.95 to 13.30 - UP over 400 PERCENTAnd we just finished tracking EMRH - UP from 1.00 to 2.08 in just one day. EMRH is a great new company doing business in the fastest growing market in the world - CHINA.Now we are tracking another great company focusing on the Chinese market - KWBT - A HOT NEW BIO-TECH5-Day Target: .8510-Day Target: 1.353-Month Target: 2.50KWBT is a HOT NEW BIO-TECH with manufacturing centers in mainland CHINA.HighLights:*The Chinese agricultural marketplace has a GDP of $180 billion and is 14.5% of the National GDP.*KWBT's main product is a Photosynthesis Biological Catalyst ("Ph-BC"). The first commercialization products in China developed over the last 20 years.*Phase 1 production capacity of 150 tons annually is completed. A 3-year production plan would apply to 12,355,000 acres.*Stimulates plant growth and increases crop yield by as much as 25% based on 3 year field tests.*Sales distribution to over 300 locations throughout China.*Strong Government support with $1.8 million subsidized loan from Chinese government, a $1.2 million loan from the Shandong Province.And with such recent Press Releases as:* June 29 - KWBT Bio-Tech Expands Sales and Marketing Efforts Adding 17 New Customers. Read the whole story HERE.* July 9 - KWBT Bio-Tech Signs Cooperative Letter of Intent. Read the whole story HERE. Stock Tech-Tracker (STT) is not a registered financial advisory. The information presented by STT is not for purchasing or selling securities. STT compiles then distributes opinions, comments and information based on other public sources. Penny stocks are considered to be high...
- Subject: HOT-STOCK-TRACKER: HOT NEW BIO-TECH Receives $10 Million In | 3 occurrences - low | EFR occurs 7 times | View message
- ...Content-Transfer-Encoding: 7Bit Equity Funding Review...Breaking News After the Closing Bell on KWBTCITY OF INDUSTRY, CA Kiwa Bio-Tech Products Group Corporation, (OTC.BB: KWBT) announced today that it has received a $10 million financial commitment from Cornell Capital Partners, LP.This is the REAL DEAL. Cornell Capital has funded some very successful companies in the past.As of June 2004, the Cornell group has made available in excess of $800 million for over 100 publicly traded corporations, including and listed on the NSADAQ, AMEX, and OTCBB markets. Since 2001, they are the most active investor in structured private placements, globally; and by the end of 2002 were ranked #1 both in "all PIPE" and "structured PIPE" transactions with 33 and 32 transactions, respectively. Here are just a few of Cornell's success stories:Reliv International (NASDAQ: RELV)On Feb. 26, 2004 it was announced !...
- ...that RELV was to receive $5 million in funding. Stock Price on Feb. 26 was $6.38. RELV peaked at $11.50 on 20 May, 2004. RELV, based in St. Louis, manufactures and distributes several lines of food products, including nutritional and fiber supplements, diet management products, functional foods and sports drink mixes. NeoMedia Technologies (OTC.BB: NEOM)NEOM received a $10 million equity line of credit from Cornell Capital in Feb. 2003. Stock price at that time of financing was $0.02. In Sept. 2003, NEOM peaked at $0.28. NEOM is an international leader in print-to-internet technology.CTI Industries Corporation (NASDAQ: CTIB)CTIB just got their financing wheels in motion. CTIB announced on 7 July, 2004 that it had entered into a Standby Equity Distribution Agreement ("SEDA") with Cornell Capital for $5 million. CTIB went from $2.20 on 8 July to 2.72 on 9 July.As you can see, where Cornell Capital's money goes, succ! ess follows. Now is the time to get into KWBT. Equity Funding Review (EFR) is not a registered financial advisory. The information presented by EFR is not for purchasing or selling securities. EFR compiles then distributes opinions, comments and information based on other public sources. Penny stocks are considered to be highly speculative and may be unsuitable for all but very aggressive investors. EFR does not hold nor does it plan to hold a position in this stock. This Profile was a paid advertisement by a third party not affiliated with the profiled company. EFR was compensated two thousand dollars to publish and distribute this report. Paid advertisements for a third party do not necessarily reflect the views of EFR. Target prices may fluctuate depending on market environments. Please always consult a registered financial advisor before making any decisions. This report is for entertainment and advertising purposes only and sho!...